Impact of the Postponement of Surgery on Postoperative Morbidity After Sars-cov-2 Infection

NCT05336110 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5189

Last updated 2022-07-18

No results posted yet for this study

Summary

The deployment of vaccination against SARS-CoV-2 from 2021 led to a modification in June 2021of previous recommendations concerning the postponing scheduled surgery suggesting local adaptations of this delay if epidemic developments appear. Today, the evolutions of the pandemic make these recommendations obsolete and impose the updating of the data produced during the first epidemic wave of 2020. Among these evolutions, the two most important are the existence of a large vaccination coverage on the one hand and the emergence of variants of lesser severity on the other hand

Conditions

  • SARS CoV 2 Infection

Interventions

OTHER

Postponing surgery

Postponing surgery for patients with Sars-cov-2 infection

Sponsors & Collaborators

  • Société Française d'Anesthésie et de Réanimation

    lead OTHER

Principal Investigators

  • Marc GARNIER, MD · HOPITAL TENON - PARIS

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-14
Primary Completion
2022-05-13
Completion
2022-05-13

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05336110 on ClinicalTrials.gov